Search research articles
Contact Us
Filters
Showing results (41-50 of 133) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
The biology of metastasis to a sanctuary site
Diane Palmieri, Ann F Chambers, Brunhilde Felding-Habermann, et al.
BJU International
|
September 13, 2005
Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder
Celina Ang, Ann F Chambers, Alan B Tuck, et al.
Nutrition and Cancer
|
December 21, 2006
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract
Peter J Ferguson, Elzbieta M Kurowska, David J Freeman, et al.
Cancer
|
September 5, 2002
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma
Sebastien J Hotte, Eric W Winquist, Larry Stitt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Paul Goss, Alison L Allan, David I Rodenhiser, et al.
The Journal of Nutrition
|
June 3, 2004
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines
Peter J Ferguson, Elzbieta Kurowska, David J Freeman, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2008
Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression
Jie Xu, Lesley H Souter, Ann F Chambers, et al.
Expert Opinion on Therapeutic Targets
|
July 21, 2018
Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer
Pieter H Anborgh, Danny J Lee, Pieter F Stam, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
April 7, 2016
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis
Jennifer M Kirstein, M Nicole Hague, Patricia M McGowan, et al.
Journal of Visualized Experiments : Jove
|
March 6, 2015
Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo
Mateusz Rytelewski, Adrian Buensuceso, Hon S Leong, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 133) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
The biology of metastasis to a sanctuary site
Diane Palmieri, Ann F Chambers, Brunhilde Felding-Habermann, et al.
BJU International
|
September 13, 2005
Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder
Celina Ang, Ann F Chambers, Alan B Tuck, et al.
Nutrition and Cancer
|
December 21, 2006
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract
Peter J Ferguson, Elzbieta M Kurowska, David J Freeman, et al.
Cancer
|
September 5, 2002
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma
Sebastien J Hotte, Eric W Winquist, Larry Stitt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Paul Goss, Alison L Allan, David I Rodenhiser, et al.
The Journal of Nutrition
|
June 3, 2004
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines
Peter J Ferguson, Elzbieta Kurowska, David J Freeman, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2008
Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression
Jie Xu, Lesley H Souter, Ann F Chambers, et al.
Expert Opinion on Therapeutic Targets
|
July 21, 2018
Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer
Pieter H Anborgh, Danny J Lee, Pieter F Stam, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
April 7, 2016
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis
Jennifer M Kirstein, M Nicole Hague, Patricia M McGowan, et al.
Journal of Visualized Experiments : Jove
|
March 6, 2015
Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo
Mateusz Rytelewski, Adrian Buensuceso, Hon S Leong, et al.
Page
of 14